For seven years the Eryfotona Actinica was a single product with a single argument: zinc oxide for the filter, a photolyase enzyme for the damage that gets past it, and a price that dermatology offices could justify to patients with sun-damaged skin. Patients kept asking for a tint, and the brand's answer for a while was to point them at the Eryfotona Ageless, a different product with a different positioning. In June 2026 ISDIN registered a proper Actinica Tinted with the FDA, and the most interesting thing about it is not the colour but the filter. This is not the zinc formula with iron oxides stirred in. It is a titanium dioxide sunscreen, 16.1 percent, built from the ground up to carry a tint, and that choice explains almost everything about how it feels and what it protects against.
The drug-facts label lists titanium dioxide as the only active. Below it the inactive list reads like a modern water-in-silicone fluid: a light ester and dimethicone, an alkane, dicaprylyl carbonate and silica for slip, dibutyl adipate, denatured alcohol eighth on the list, two dipolyhydroxystearate emulsifiers, then the iron oxides that give it colour. Butyloctyl salicylate, an emollient that quietly boosts SPF, and a film-former follow, with panthenol, fragrance, a hectorite clay to keep the pigments suspended, vitamin E in two forms, and, near the end, lecithin and plankton extract, which is how the label spells DNA Repairsomes: the photolyase enzyme from a cyanobacterium, carried in liposomes so it can sit on the skin and undo the cyclobutane pyrimidine dimers that UV leaves behind. Nothing about the supporting cast is new to the Eryfotona line; what is new is the filter beneath it.
The zinc-versus-titanium question is not trivial and deserves a straight answer. Both minerals pass the FDA's critical-wavelength test for a broad-spectrum label, and 16 percent titanium dioxide at SPF 50 is a genuine, effective sunscreen. But titanium dioxide's absorption tails off across the longest UVA-1 wavelengths, the ones that reach deepest into the dermis and drive photoaging and pigmentation, where zinc oxide keeps working. ISDIN traded that depth for two things. First, texture: titanium dioxide disperses into a thinner emulsion that sets fast, takes a tint evenly and does not go chalky, which is why this feels like a fluid rather than the untinted Actinica's lotion. Second, and this is the part that makes the trade sensible, the iron oxides. Pigments that give a sunscreen its colour also absorb visible light, including the blue-violet band that has been shown to deepen melasma and post-inflammatory pigmentation in medium and darker skin, and that band is one no UV filter, zinc included, does anything about. For a patient whose problem is dark spots, this bottle protects against something the untinted Actinica cannot, and loses a little of what it can.
In use it is very good at the thing tinted sunscreens are usually bad at, which is disappearing. A hard shake, two finger-lengths, and it spreads in a few strokes into a sheer warm-beige veil that blurs redness and evens tone without looking like a product; it sets in about two minutes to a soft satin that takes foundation or powder without pilling. There is a faint fragrance and a whiff of alcohol on application, both gone within a minute, and no white cast at any point. The single universal shade reads as a light bronze on fair skin, a near-match on medium, and slightly ashy on deep skin until a second pass blends it, which is the honest limit of any one-tint sunscreen; it is a base for makeup, not a replacement for it.
The complaints are the line's old ones plus one new one. Fragrance and denatured alcohol are choices a dermatology brand does not need to make in a sunscreen aimed at damaged skin, and rosacea-prone or fragrance-allergic faces will need to look elsewhere. The one-shade tint excludes the ends of the tone range. The new criticism is the UVA-1 point above, and it matters most for exactly the person the Actinica name is aimed at: someone with a history of actinic damage who wants the deepest coverage available should still be on the zinc version, tint or no tint. The photolyase, meanwhile, is a real enzyme with real studies behind it, mostly in ISDIN's own European medical-device formulations for actinic keratosis patients, and the fair reading is that it is a plausible bonus on top of a good filter rather than a reason to pay the premium on its own.
That premium is seventy-three dollars for 100 millilitres, or forty-six for the 50 millilitre travel size, and at the labelled two finger-lengths a day the large bottle lasts about seven weeks, which makes the annual cost of wearing it properly north of five hundred dollars. The formulation is excellent and the brand's research pedigree is genuine, so this is not the case of a luxury jar hiding a drugstore list; it is a very good sunscreen priced for the dermatology office rather than the drugstore shelf, and the reader has to decide whether the enzyme and the pedigree are worth roughly three times what a well-made tinted mineral from a mass brand costs. There are no reviews yet to check that judgement against.
For melasma, post-inflammatory marks, post-procedure skin and anyone who wants a dermatology-grade tinted mineral that vanishes under makeup, this is an easy product to like and a hard one to budget. For the bare-faced patient with a serious sun-damage history, the untinted zinc Actinica remains the stronger choice on UVA depth. And for anyone who reacts to fragrance or alcohol, the whole Eryfotona line remains, for now, a near miss.
